Real-world experience of ocrelizumab in multiple sclerosis in an Arab population

OBJECTIVE: Pivotal clinical trials revealed good clinical efficiency of ocrelizumab while having a good safety profile in the management of multiple sclerosis (MS). However, real-world data of ocrelizumab in daily clinical practice remain scarce. The aim of this study was to evaluate the preliminary...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia-Cañibano, Beatriz, Ouanes, Sami, Ganesan, Gowrii Saswathy, Yousuf, Wajiha, Humos, Basel, Baig, Tehniyat, Ibrahim, Faiza, Singh, Rajvir, Deleu, Dirk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530478/
https://www.ncbi.nlm.nih.gov/pubmed/34692185
http://dx.doi.org/10.1080/21556660.2021.1989193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530478/
https://www.ncbi.nlm.nih.gov/pubmed/34692185
http://dx.doi.org/10.1080/21556660.2021.1989193

Ejemplares similares